Skip to content

Drug interactions

Maprotiline + Oxybutynin transdermal

Severity: Moderate

Maprotiline and Oxybutynin transdermal: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Oxybutynin is an antimuscarinic and maprotiline has anticholinergic properties. Even by the transdermal route, systemic exposure is sufficient to add to dry mouth, constipation, urinary retention, blurred vision and cognitive effects. Older patients are most susceptible.

What this interaction means in plain words

Maprotiline and Oxybutynin transdermal can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Evidence level: Moderate

Why it happens

Additive antimuscarinic effects at peripheral and central muscarinic receptors.

What to do

Monitor for anticholinergic adverse effects and cognitive changes, and reassess the need for both agents in older adults. Consider a non-anticholinergic bladder treatment if symptoms develop.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Maprotiline and Oxybutynin transdermal, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Maprotiline with Oxybutynin transdermal?

MediHelp rates the interaction as moderate. Maprotiline and Oxybutynin transdermal can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Oxybutynin is an antimuscarinic and maprotiline has anticholinergic properties. Even by the transdermal route, systemic exposure is sufficient to add to dry mouth, constipation, urinary retention, blurred vision and cognitive effects. Older patients are most susceptible.

How serious is the interaction between Maprotiline and Oxybutynin transdermal?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for anticholinergic adverse effects and cognitive changes, and reassess the need for both agents in older adults. Consider a non-anticholinergic bladder treatment if symptoms develop.

What other medicines interact with Maprotiline?

MediHelp also lists interactions of Maprotiline with, for example, Arsenic trioxide, Disopyramide, Dofetilide. The full list is on the Maprotiline page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in